Virtual Medicinal Product (VMP)
-
Levothyroxine sodium 50microgram tablets
Name Details
Current Name
Levothyroxine sodium 50microgram tablets
|
Start Date
01-12-2004
|
End Date
|
Previous Name
Levothyroxine sodium 50microgram tablets
|
Start Date
28-10-2004
|
End Date
30-11-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
H03AA01
BNF |
Current BNF
06020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06020100
|
Start Date
11-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39698611000001106 |
26-05-2021 |
|
374295007 |
17-01-2007 |
25-05-2021 |
325319007 |
SOT |
16-01-2007 |
VMP Ingredients
Name
Levothyroxine sodium anhydrous
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTM
Levothyroxine
-
VMP
(Current) Levothyroxine sodium 50microgram tab...
Virtual Medicinal Product Pack (VMPP) Information